(202) 558-2030 info@nidellaw.com

SSRI & SNRI Antidepressant Use During Preganancy

Evidence links to Autism and ASD Related Injuries

 

 SSRI and SNRI Antidepressant Use Increase Risk of Autism and ASD in Offspring

New evidence published today in the Journal of the American Medical Association Pediatrics provides further confirmation of a link between antidepressant usage by mothers during pregnancy and the increased risk for autism and ASD-related injuries in maternal offspring.  The list of relevant drugs includes is provided below.  If you were prescribed one or more of these drugs while pregnant and have a child suffering from autism or a related injury, please CONTACT US by filling out the form below.

  • Celexa®
  • Lexapro®
  • Prozac®
  • Luvox®
  • Paxil®
  • Zoloft®
  • Pristine®
  • Cymbalta®
  • Effexor®/Effexor XR®
  • Savella®
  • Fetzima®

The conclusions section from the abstract of the study is shown below and the article can be found here:

Conclusions and Relevance  Use of antidepressants, specifically selective serotonin reuptake inhibitors, during the second and/or third trimester increases the risk of ASD in children, even after considering maternal depression. Further research is needed to specifically assess the risk of ASD associated with antidepressant types and dosages during pregnancy.

This study further builds on mounting evidence of the link between ASD and maternal antidepressant usage.   Last year, a research paper published by scientists at the Johns Hopkins Bloomberg School of Public Health provided evidence of a connection between pregnant mothers use of certain type of medications, known as selective seratonin reuptake inhibitors or “SSRIs”, used in the treatment of depression, anxiety, and other medical conditions, and an increased risk for offspring with autism spectrum disorder or ASD.  This study demonstrated that the greatest risk is associated with prenatal SSRI use during the first trimester of pregnancy, where the risk of having an autistic boy was nearly 3-times greater than for those mothers that were not given the medication.

Now there is evidence that these drugs may lead to an increased risk of ASD disorders in all three trimesters of fetal development.

We are now in the final stages of evaluating the evidence supporting filing lawsuits against the manufacturers of these drugs for failing to identify and warned these risks.

If you are a parent with a child that has been diagnosed with an autism spectrum condition and believe that it may be attributable to the use of an SSRI or SNRI antidepressant during pregnancy, we ask that you please complete the following form.

You may have a claim against the manufacturers or distributors of these potentially dangerous drugs.  Fill out the following form for a FREE CONSULTATION.

Environmental Health News

One in four of the world’s children will be living in areas with extremely limited water resources b [...]

Officials at a medical school in New York State say they will investigate a faculty member who, acco [...]

Monsanto is facing more pressure to compensate farmers and farm workers who allege that its leading [...]

As the EPA becomes the subject of focus for major cuts under President Trump's proposed budget, [...]

Children as young as eight, working in the tanneries of Bangladesh producing leather that is in dema [...]

The Alabama State Department of Education is moving forward with plans to test the drinking water in [...]

The chemical detection is the latest example of PFCs being found at levels above recommended health [...]

Satellite data show seasonal and regional changes in global ozone, ammonia levels. [...]

People living close to trees and green spaces are less likely to be obese, inactive, or dependent on [...]

At least 26 people died from hunger in the semi-autonomous Jubbaland region of southern Somalia in j [...]